Valuation: Eckert & Ziegler SE

Market Cap 845M 972M 789M 724M 1.37B 92.65B 1.39B 9.3B 3.64B 46.2B 3.65B 3.57B 152B P/E 2026 *
16.2x
P/E 2027 * 15.3x
Enterprise Value 729M 838M 680M 625M 1.18B 79.92B 1.2B 8.02B 3.14B 39.85B 3.15B 3.08B 131B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.11x
Free-Float
67.36%
Yield 2026 *
1.44%
Yield 2027 * 1.48%
1 day-1.30%
1 week+0.96%
Current month-0.58%
1 month-14.42%
3 months-7.43%
6 months-9.30%
Current year-10.32%
1 week 13.54
Extreme 13.54
14
1 month 13.11
Extreme 13.11
16.14
Current year 13.11
Extreme 13.11
16.82
1 year 13.11
Extreme 13.11
21.45
3 years 9.67
Extreme 9.6667
23.07
5 years 9.67
Extreme 9.6667
46.92
10 years 1.73
Extreme 1.7287
46.92
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%+0.96% - - 980M
+3.30%+5.09%+23.74%-39.58% 15.7B
+4.12%+7.51%+8.10%+116.74% 1.77B
+5.61%+5.23%-22.36%-78.66% 1.14B
+1.73%+5.26%-43.43%-52.03% 655M
-0.55%+5.65%-45.94%-52.30% 543M
+6.52%+8.56%+66.02%-47.37% 472M
+4.26%+4.08%-50.62%-46.78% 374M
+0.54%+4.37%-13.25%-30.02% 368M
+5.12%+18.09%+31.15%+33.44% 329M
Average +2.93%+5.74%-5.18%-21.84% 2.37B
Weighted average by Cap. +3.21%+5.20%+15.25%-28.40%

Financials

2026 *2027 *
Net sales 319M 367M 297M 273M 515M 34.95B 524M 3.51B 1.37B 17.43B 1.38B 1.35B 57.48B 340M 392M 318M 292M 550M 37.34B 560M 3.75B 1.47B 18.62B 1.47B 1.44B 61.42B
Net income 51.68M 59.46M 48.25M 44.29M 83.52M 5.67B 84.97M 569M 223M 2.83B 223M 218M 9.32B 53.08M 61.08M 49.56M 45.5M 85.79M 5.82B 87.28M 584M 229M 2.9B 229M 224M 9.58B
Net Debt -116M -134M -108M -99.5M -188M -12.73B -191M -1.28B -501M -6.35B -502M -491M -20.94B -126M -144M -117M -108M -203M -13.76B -206M -1.38B -541M -6.86B -542M -530M -22.64B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
03/08/26 EUR 13.54 -1.38% 18,269
31/07/26 EUR 13.73 -0.87% 37,077
30/07/26 EUR 13.85 -0.07% 59
29/07/26 EUR 13.86 +2.67% 150
28/07/26 EUR 13.50 -0.15% 463
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.50EUR
Average target price
21.60EUR
Spread / Average Target
+60.00%

Quarterly revenue - Rate of surprise